Log in

Relevant bibliographies by topics / Anti-hepatitis-B / Journal articles

To see the other types of publications on this topic, follow the link: Anti-hepatitis-B.

Journal articles on the topic 'Anti-hepatitis-B'

Author: Grafiati

Published: 7 June 2025

Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Anti-hepatitis-B.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Aghayeva, S. Сh, and A. A. Hidayatov. "THE IMPACT OF OCCULT HEPATITIS B INFECTION ON THE COURSE OF CHRONIC HEPATITIS C TREATMENT WITH DIRECT-ACTING ANTIVIRALS." Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії 22, no. 1 (2022): 4–8. http://dx.doi.org/10.31718/2077-1096.22.1.4.

Full text

Abstract:

The prevalence of viral hepatitis B and C in Azerbaijan is 3.2% and 4.3% respectively. The incidence of occult hepatitis B has not been previously studied. The purpose of this study is to assess the prevalence of occult hepatitis B infection among patients with chronic hepatitis C, as well as to assess the impact of occult hepatitis B on the progression of liver disease and to identify the likelihood of viral/clinical reactivation of occult hepatitis B during treatment with direct-acting antiviral drugs. Results. The study included 164 patients with chronic hepatitis C with the absence of over

APA, Harvard, Vancouver, ISO, and other styles

2

Rakhmani, Dinna, Aini Luthfiah Hayati, and Tini Elyn Herlina. "PROFIL ANTI-HBS PADA MAHASISWA TEKNOLOGI LABORATORIUM MEDIS POLTEKKES KEMENKES BANJARMASIN." Medika Kartika Jurnal Kedokteran dan Kesehatan, Volume 5 No 3 (September 29, 2022): 265–74. http://dx.doi.org/10.35990/mk.v5n3.p265-274.

Full text

Abstract:

Hepatitis B adalah infeksi yang disebabkan oleh virus Hepatitis B dan menyerang jaringan hati. Virus Hepatitis B dapat menular melalui darah dan cairan tubuh penderita. Infeksi Hepatitis B dapat dicegah dengan melakukan vaksinasi. Kekebalan tubuh terhadap infeksi virus Hepatitis B ditandai dengan adanya kandungan Anti-HBs. Anti-HBs merupakan antibodi protektif terhadap infeksi virus Hepatitis B. Kadar protektif Anti-HBs terhadap infeksi virus Hepatitis B sebesar ≥10 mIU/mL. Penelitian ini bertujuan untuk mengetahui profil anti-HBs pada mahasiswa Teknologi Laboratorium Medis Poltekkes Kemenkes

APA, Harvard, Vancouver, ISO, and other styles

3

Balegha, Augustine Ngmenemandel. "Factors influencing the utilisation of anti-HBs titre testing services among nursing students in Northwest Ghana: A cross-sectional study." PLOS Global Public Health 4, no. 4 (2024): e0003160. http://dx.doi.org/10.1371/journal.pgph.0003160.

Full text

Abstract:

Understanding the impact of hepatitis B testing, vaccination, the number of vaccine doses, and socio-demographics on post-vaccination anti-HBs titre testing, is essential for hepatitis B prevention. The aim of the study was to determine the prevalence of hepatitis B testing, hepatitis B vaccination, number of vaccine doses received, socio-demographic characteristics, and their impact on anti-HBs titre testing among nursing students in Northwest Ghana. A stratified sample of 402 nursing students from Wa and Lawra nursing colleges in Ghana’s Upper West Region was surveyed in November 2020 using

APA, Harvard, Vancouver, ISO, and other styles

4

Md. Nazmul Islam, Md. Shohanur Rahaman, Sadia Islam, et al. "Serological profile and interpretation of different hepatitis B virus marker." World Journal of Biology Pharmacy and Health Sciences 14, no. 3 (2023): 213–18. http://dx.doi.org/10.30574/wjbphs.2023.14.3.0265.

Full text

Abstract:

Hepatitis B virus (HBV) infections are a global public health problem. Chronic hepatitis B (CHB) infection is associated with an increased risk of cirrhosis, hepatic decompensation and hepatocellular carcinoma (HCC). In virus-infected liver cells, HBsAg is produced in excess and secreted into the blood, where it serves as a marker for active infection and infectivity. Currently, recombinant HBsAg is used for HBV vaccination, and the development of antibody to HBsAg is typically associated with protective immunity. The likelihood of developing CHB is related to the age at which infection is acq

APA, Harvard, Vancouver, ISO, and other styles

5

Md., Nazmul Islam, Shohanur Rahaman Md., Islam Sadia, et al. "Serological profile and interpretation of different hepatitis B virus marker." World Journal of Biology Pharmacy and Health Sciences 14, no. 3 (2023): 213–18. https://doi.org/10.5281/zenodo.8318100.

Full text

Abstract:

Hepatitis B virus (HBV) infections are a global public health problem. Chronic hepatitis B (CHB) infection is associated with an increased risk of cirrhosis, hepatic decompensation and hepatocellular carcinoma (HCC). In virus-infected liver cells, HBsAg is produced in excess and secreted into the blood, where it serves as a marker for active infection and infectivity. Currently, recombinant HBsAg is used for HBV vaccination, and the development of antibody to HBsAg is typically associated with protective immunity. The likelihood of developing CHB is related to the age at which infection is acq

APA, Harvard, Vancouver, ISO, and other styles

6

Honorati, M. C., A. Palareti, P. Dolzani, and A. Facchini. "Planning for anti-hepatitis B revaccination." Immunology Letters 56 (May 1997): 289. http://dx.doi.org/10.1016/s0165-2478(97)86162-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Honorati, M. "Planning for anti-hepatitis B revaccination." Immunology Letters 56, no. 1-3 (1997): 289. http://dx.doi.org/10.1016/s0165-2478(97)88000-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Z Arthamin, Maimun. "MUTANT HBV INFECTION ON aa143 (T143S)." INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 15, no. 2 (2018): 68. http://dx.doi.org/10.24293/ijcpml.v15i2.949.

Full text

Abstract:

Lebih dari satu dasawarsa lalu, segi penting mutan virus hepatitis B (HBV) telah teralihkan dari sejumlah kenyataan teoriyang tidak diketahui menjadi faktor untuk dipertimbangkan saat mendiagnosis penyakit. Laporan mutan virus hepatitis B (HBsAg)dalam petentu “suatu” telah diperkenalkan. Mutan diisolasi dari penderita seorang laki-laki tanpa gejala berumur 25 tahun, yangditemukan positif HBsAg tetap, positif untuk antibodi permukaan anti-hepatitis B(anti-HBs) dan negatif untuk kedua penutuplengkap virus hepatitis B antigen (HbeAg) serta penutup lengkap anti-hepatitis B antibodi (anti-HBe). Rea

APA, Harvard, Vancouver, ISO, and other styles

9

MOSSONG, J., L. PUTZ, S. PATINY, and F. SCHNEIDER. "Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg." Epidemiology and Infection 134, no. 4 (2006): 808–13. http://dx.doi.org/10.1017/s0950268805005789.

Full text

Abstract:

A prospective seroepidemiological survey was carried out in Luxembourg in 2000–2001 to determine the antibody status of the Luxembourg population against hepatitis A virus (HAV) and hepatitis B virus (HBV). One of the objectives of this survey was to assess the impact of the hepatitis B vaccination programme, which started in May 1996 and included a catch-up campaign for all adolescents aged 12–15 years. Venous blood from 2679 individuals was screened for the presence of antibodies to HAV antigen and antibodies to hepatitis B surface antigen (anti-HBs) using an enzyme immunoassay. Samples posi

APA, Harvard, Vancouver, ISO, and other styles

10

Caballero, L. Requena, C. Requena Caballero, I. Requena Caballero, et al. "Prevalence and risk factors of hepatitis B in Spanish prostitutes." Epidemiology and Infection 99, no. 3 (1987): 767–74. http://dx.doi.org/10.1017/s0950268800066620.

Full text

Abstract:

SUMMARYEighty prostitutes wore tested by solid-phase radioimmunoassay for serum markers of hepatitis B virus (HBV). Of 8 (10%) with hepatitis B surface antigen (HBsAg), 6 (75%) also had hepatitis Be antigen (HBeAg). Antibodies to HBsAg (anti-HBs) and to hepatitis B core antigen (anti-HBc) were found in 52 (65%). Antibodies to HBeAg (anti-HBe) were positive in 32 (40%). Anti-HBc alone was found in 5 (6%) and anti-HBs alone in 2 (2%). Sixty-seven (84%) were positive for at least one HBV marker and 13 (16%) were still susceptible to infection. Hepatitis B markers were more prevalent in prostitute

APA, Harvard, Vancouver, ISO, and other styles

11

Shrestha, Shailendra, and Pratap Roy. "Hepatitis B Virus Vaccination Status and Anti Hepatitis B Surface Antibody Titer among the Health Care Workers of a Hemodialysis Unit." Journal of Nobel Medical College 9, no. 2 (2020): 23–27. http://dx.doi.org/10.3126/jonmc.v9i2.33354.

Full text

Abstract:

Background: Health care workers are in high risk of getting infected with hepatitis B virus. A large proportion of them do not receive a 3-dose series of hepatitis B vaccination and have anti hepatitis B surface antibody titer <10 mIU/ml. Materials and Methods: Health care workers of the hemodialysis unit were included from March 2019 to March 2020 and were interviewed about hepatitis B vaccination status. Serum samples of the participants were analyzed for anti hepatitis B surface antibody titer. Participants with antibody titer of <10mIU/ml were given a 3-dose series of hepatitis

APA, Harvard, Vancouver, ISO, and other styles

12

Kavitha, Latha M. L., L. Vidyadhar, Sujatha Bogadi, and Lakshmi G. Jyothi. "Prevalence of Antibody Titres and Hepatitis B Virus Infection among Healthcare Workers at a Tertiary Care Hospital in India." International Journal of Pharmaceutical and Clinical Research 16, no. 4 (2024): 964–68. https://doi.org/10.5281/zenodo.11180325.

Full text

Abstract:

<strong>Background: </strong>The danger of occupational exposure to several blood-borne diseases, such as HIV, Hepatitis B, and Hepatitis C virus infections, is significant for healthcare workers (HCWs). Of these, the only infection that may be prevented with vaccine is hepatitis B, which is also the most contagious. Healthcare professionals in underdeveloped nations have very low vaccination rates against Hepatitis B due to a number of factors, including low risk assessment, ignorance, and low priority from the health administrations of both public and private hospitals. In India, 28% of

APA, Harvard, Vancouver, ISO, and other styles

13

de Souza, Marilen Queiroz, Alexsandro Sobreira Galdino, José Carlos dos Santos, et al. "A Recombinant Multiepitope Protein for Hepatitis B Diagnosis." BioMed Research International 2013 (2013): 1–7. http://dx.doi.org/10.1155/2013/148317.

Full text

Abstract:

Hepatitis B is a liver inflammation caused by hepatitis B virus (HBV) and can be diagnosed in clinical stage by hepatitis B core antibody from IgM class (anti-HBcIgM). Hepatitis B core antibody from IgG class (Anti-HBcIgG) appears quickly after IgM, reaching high titers in chronic hepatitis, and remains even after cure. Since hepatitis B core antibody (anti-HBc) is the first antibody identified and sometimes the only marker detected during the course of infection, it can be used both to indicate HBV acute infection (anti-HBc-IgM) and to identify individuals who have come into contact with the

APA, Harvard, Vancouver, ISO, and other styles

14

Mukherjee, Kheya, Debojyoti Bhattacharjee, and Goutam Chakraborti. "Prevalence of hepatitis B and hepatitis C virus infection in repeatedly transfused thalassemics in a tertiary care hospital in eastern India." International Journal of Research in Medical Sciences 5, no. 10 (2017): 4558. http://dx.doi.org/10.18203/2320-6012.ijrms20174596.

Full text

Abstract:

Background: Patients of thalassemia who are conventionally treated by a regular transfusion regimen are at a risk of developing transfusion transmissible infections, including hepatitis. The present study was conducted to assess the prevalence of hepatitis B and hepatitis C virus infections among repeatedly transfused thalassemia patients.Methods: A total of 207 patients of beta-thalassemia, who had received at least 10 transfusions were tested for hepatitis B surface antigen (HBsAg) and anti-HCV antibody using enzyme linked immunosorbant assay (ELISA).Results: The overall number of anti-hepat

APA, Harvard, Vancouver, ISO, and other styles

15

GUIMARÃES, Maia Nogueira Crown, Tila FACINCANI, and Sigrid De Sousa dos SANTOS. "Hepatitis B status in hemodialysis patients." Arquivos de Gastroenterologia 54, no. 4 (2017): 356–58. http://dx.doi.org/10.1590/s0004-2803.201700000-34.

Full text

Abstract:

ABSTRACT BACKGROUND: Patients on chronic dialysis present a high prevalence of hepatitis B virus infection. Despite infection-control practices, surveillance of serological markers, and hepatitis B vaccination, there are still outbreaks of the disease in dialysis centers. OBJECTIVE: This study aims to assess the serologic and vaccination status for hepatitis B in hemodialysis patients. METHODS: This cross-sectional study assessed serologic markers and hepatitis B vaccination status of chronic kidney disease patients on regular dialysis program in São Carlos, SP, Brazil. Patients without inform

APA, Harvard, Vancouver, ISO, and other styles

16

LIAW, YUN-FAN. "Hepatitis flares and hepatitis B e antigen seroconversion: Implication in anti-hepatitis B virus therapy1." Journal of Gastroenterology and Hepatology 18, no. 3 (2003): 246–52. http://dx.doi.org/10.1046/j.1440-1746.2003.02976.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Pan, Lingyun, Suyan Shen, and Yifan Ye. "Dauricine Exerts Anti-Hepatitis B Virus Effects by Inhibiting Hepatitis B Virus Promoter Activity in Human Hepatoblastoma Cells." Current Topics in Nutraceutical Research 22, no. 2 (2024): 830–34. http://dx.doi.org/10.37290/ctnr2641-452x.22:830-834.

Full text

Abstract:

This study explores the anti-Hepatitis B virus effect and the mechanism of Dauricine on HepG2.2.15 cells. The study employed an ELISA kit to detect expressed levels of hepatitis B surface antigen, hepatitis B e antigen, and hepatitis B virus DNA in a culture medium; RT-qPCR was used to measure hepatitis B virus 3.5 kb RNA and cccDNA expression; the activity of hepatitis B virus promoter (Cp, S1p, and Xp) was assessed using a luciferase reporter gene; Western blotting was used to detect the expression of p65, p-p65, IkappaB-α, and p-IkappaB-α. Dauricine reduces the expression of HBsAg, HBeAg, a

APA, Harvard, Vancouver, ISO, and other styles

18

Tong, Myron J., Ann M. Howard, Gary C. Schatz, et al. "A Hepatitis B Vaccination Program in a Community Teaching Hospital." Infection Control 8, no. 3 (1987): 102–7. http://dx.doi.org/10.1017/s0195941700067266.

Full text

Abstract:

AbstractPrior to offering the hepatitis B (HB) vaccine, a prescreen for hepatitis B virus (HBV) antibodies was conducted in a 565 bed hospital in Pasadena, California. Antibodies to the hepatitis B virus were detected in 14.5% of 1,745 employees tested. There was a significantly higher prevalence in those with a previous history of hepatitis, blood transfusions, exposure to nee-dlesticks, number of years in the same occupation, and in the same hospital work area. Employees of Asian extraction (33.3%) and blacks (23.1%) had a higher prevalence of antibodies to the hepatitis B virus than Hispani

APA, Harvard, Vancouver, ISO, and other styles

19

Muwanda, Fahad, Edward Kiyonga, Joan Nambafu, et al. "Serological Status of Vaccine and Hepatitis B Virus Exposure Among Children Under 5 and Aged 15–17 Years in Kampala, Uganda." Livers 4, no. 4 (2024): 550–61. http://dx.doi.org/10.3390/livers4040039.

Full text

Abstract:

Background: Pediatric hepatitis B virus (HBV) serostatus remains variably characterized, hardly determined at times, or documented as part of national monitoring of the Extended Programs for Immunization (EPI). Methods: We cross-sectionally characterized the seroprevalence of HBV vaccine and/or infection status among 501 and 288 children <5 and 15–17 years old, respectively, in Kawempe Division, Kampala, Uganda, between May and August 2023. These children received HBV vaccination under the Uganda National Extended Program on Immunizations (UNEPI). Samples were qualitatively screened for hep

APA, Harvard, Vancouver, ISO, and other styles

20

Saputro, Anjar Hermadi, Aluicia Anita Artarini, Daryono Hadi Tjahjono, and Sophi Damayanti. "The long and stumble way to find potential active compounds from plants for defeating hepatitis B and C: review." Pharmacia 69, no. 3 (2022): 699–708. http://dx.doi.org/10.3897/pharmacia.69.e85160.

Full text

Abstract:

Hepatitis is a liver illness caused by virus such as hepatitis A virus, hepatitis B virus and hepatitis C virus. Hepatitis B and C are considerably more usual and induce more cirrhosis and dead worldwide than hepatitis A. Although drugs that are currently often used in the medication of hepatitis B and C, the finding of recent drug from various resources including herbal has been intensively developed. Therefore, the purpose of this review is to consider the possibility of plant’s compounds as anti-HBV and anti-HCV. From the results of a review of several articles, several plant’s compound hav

APA, Harvard, Vancouver, ISO, and other styles

21

Saputro, Anjar Hermadi, Aluicia Anita Artarini, Daryono Hadi Tjahjono, and Sophi Damayanti. "The long and stumble way to find potential active compounds from plants for defeating hepatitis B and C: review." Pharmacia 69, no. (3) (2022): 699–708. https://doi.org/10.3897/pharmacia.69.e85160.

Full text

Abstract:

Hepatitis is a liver illness caused by virus such as hepatitis A virus, hepatitis B virus and hepatitis C virus. Hepatitis B and C are considerably more usual and induce more cirrhosis and dead worldwide than hepatitis A. Although drugs that are currently often used in the medication of hepatitis B and C, the finding of recent drug from various resources including herbal has been intensively developed. Therefore, the purpose of this review is to consider the possibility of plant's compounds as anti-HBV and anti-HCV. From the results of a review of several articles, several plant's compound hav

APA, Harvard, Vancouver, ISO, and other styles

22

Keck, James W., Lisa R. Bulkow, Gregory A. Raczniak, et al. "Hepatitis B Virus Antibody Levels 7 to 9 Years after Booster Vaccination in Alaska Native Persons." Clinical and Vaccine Immunology 21, no. 9 (2014): 1339–42. http://dx.doi.org/10.1128/cvi.00263-14.

Full text

Abstract:

ABSTRACTHepatitis B antibody persistence was assessed in individuals who had previously received a vaccine booster. We measured hepatitis B surface antigen antibody (anti-HBs) levels 7 to 9 years post-hepatitis B booster in individuals with primary vaccination at birth. While 95 (91.3%) of 104 participants had detectable anti-HBs (minimum, 0.1 mIU/ml; maximum, 1,029 mIU/ml), only 43 (41%) had protective levels of ≥10 mIU/ml. Pre- and week 4 postbooster anti-HBs levels were significant predictors of hepatitis B immunity at follow-up (P< 0.001). Almost all participants had detectable anti-HBs

APA, Harvard, Vancouver, ISO, and other styles

23

Rusmil, Kusnandi, Eddy Fadlyana, and Novillia S. Bachtiar. "Booster Vaksinasi Hepatitis B Terhadap Anak yang Non Responder." Sari Pediatri 12, no. 2 (2016): 88. http://dx.doi.org/10.14238/sp12.2.2010.88-91.

Full text

Abstract:

Latar belakang. Berbagai penelitian terhadap respons imun setelah imunisasi hepatitis B dengan menggunakan vaksin monovalen dari plasma maupun yang berasal dari teknik DNA rekombinan menunjukkan antara 5%-15% tidak memberikan respons (non-responder) atau kurang memberikan respons (hypo-responder) Center of Disease Control merekomendasikan terhadap anak yang tidak mempunyai tingkat proteksi antibodi (anti-Hbs) setelah mendapat imunisasi dasar, perlu diberikan 3 kali suntikan rangkaian ke-2. Setelah rangkaian ke-2 imunisasi Hepatitis B tersebut maka 30%-50% diantaranya akan mempunyai kadar yang

APA, Harvard, Vancouver, ISO, and other styles

24

Anjos, João Guilherme Grassi dos, Newton Sergio de Carvalho, Karam Abou Saab, Edward Araujo, and Jaime Kulak. "Evaluation of the Seroprevalence of Infectious Diseases in 2,445 in vitro Fertilization Cycles." Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics 43, no. 03 (2021): 216–19. http://dx.doi.org/10.1055/s-0041-1725055.

Full text

Abstract:

Abstract Objective To evaluate the seroprevalence of positive markers for syphilis, human immunodeficiency virus (HIV) I and II, human T cell lymphotropic virus (HTLV) I and II, and hepatitis B and C among women undergoing in vitro fertilization (IVF). Methods We conducted a retrospective analysis among patients who underwent IVF, between January 2013 and February 2016, and who had complete screening records. Results We analyzed 1,008 patients who underwent IVF, amounting to 2,445 cycles. Two patients (0.2%) tested positive for HIV I and II and none for HTLV I and II. Three patients (0.3%) had

APA, Harvard, Vancouver, ISO, and other styles

25

Tohme, Rania A., Bruce Ribner, Michael J. Huey, and Philip R. Spradling. "Hepatitis B Vaccination Coverage and Documented Seroprotection among Matriculating Healthcare Students at an Academic Institution in the United States." Infection Control & Hospital Epidemiology 32, no. 8 (2011): 818–21. http://dx.doi.org/10.1086/661102.

Full text

Abstract:

We evaluated hepatitis B vaccination coverage and documentation of antibody to hepatitis B surface antigen (anti-HBs) concentration among a cohort of healthcare students. Of 4,075 students, 59.8% had documentation of vaccination and 83.8% had anti-HBs concentration greater than or equal to 10 mIU/mL. Documenting hepatitis B vaccination and anti-HBs concentration among healthcare students is needed to prevent transmission in healthcare settings.

APA, Harvard, Vancouver, ISO, and other styles

26

Mokhles Mahdi Abolewaikh Almayyahi and Flayyih Hassan Shnawa Al-Hameedawi. "Hepatitis B and C Viral Infection in B-Thalassemic Children." International Journal of Research in Pharmaceutical Sciences 10, no. 4 (2019): 3733–37. http://dx.doi.org/10.26452/ijrps.v10i4.1762.

Full text

Abstract:

The main objective of this study is to show how both hepatitis B and C Viral Infection in B-Thalassemic patients occurs and a study of their liver functions. To define the occurrence of either hepatitis A or B and C viral infection across the B-Thalassemia key clients/patients in Thalassemia Center of AL-Diwanyia Maternity and Children hospital from 1st. Jan. – 1st.Nov.2017. To carry out the study, it enlisted 54 patients; 31 patients were male (57.4%) in which the male to the female ratio was 01.4:01. Results for this study revealed that 2 patients had Hepatitis B (3.7%), and 6 patients had H

APA, Harvard, Vancouver, ISO, and other styles

27

Ali, Sameen Bint, Mateen Izhar, Chetan Lal, Asma Yaqoob, Hadiqa tul Hafsa, and Asma Akram. "Frequency of Occult Hepatitis B in Pregnant Women Attending Antenatal Care Unit of a Tertiary Care Hospital." Proceedings of Shaikh Zayed Medical Complex Lahore 34, no. 4 (2020): 10–15. http://dx.doi.org/10.47489/p000s344z764mc.

Full text

Abstract:

Introduction: Occult infections (OBIs) caused by hepatitis B virus (HBV) are detected by the presence of HBV DNA without surface antigens. The prevalence of HBsAg in general population of Pakistan is around 3%, but there is no data regarding the occurrence of OBIs. Aims & Objectives: The goal of this research was to assess the frequency of occult hepatitis B infection in pregnant females presenting to antenatal care unit of Shaikh Zayed Hospital, Lahore. Place and duration of study: These samples were handled at the Microbiology Department of Shaikh Zayed Hospital, Lahore. The duration of

APA, Harvard, Vancouver, ISO, and other styles

28

Komitova, Radka T., Ani K. Kevorkyan, Maria V. Atanasova, Aneta V. Ivanova, and Elica Golkocheva-Markova. "Booster immunity – diagnosis of chronic hepatitis B viral infection." Journal of Infection in Developing Countries 13, no. 03 (2019): 255–60. http://dx.doi.org/10.3855/jidc.9929.

Full text

Abstract:

Introduction: Diagnosis of chronic hepatitis B virus (HBV) infection particularly its occult form requires monitoring and repeat serological and molecular studies. The aim of the study was to investigate the possible relation between the case of a family outbreak of hepatitis A and the finding that a member of this family was diagnosed with chronic hepatitis B. Methodology: A mother and her two sons, one previously diagnosed with chronic HBV infection, were hospitalized due to suspected acute hepatitis. Serological markers for hepatitis A, hepatitis B and hepatitis C were assessed. Addit

APA, Harvard, Vancouver, ISO, and other styles

29

Ocan, Moses, Frances Acheng, Carol Otike, Judith Beinomugisha, David Katete, and Celestino Obua. "Antibody levels and protection after Hepatitis B vaccine in adult vaccinated healthcare workers in northern Uganda." PLOS ONE 17, no. 1 (2022): e0262126. http://dx.doi.org/10.1371/journal.pone.0262126.

Full text

Abstract:

Hepatitis B vaccine has contributed to the reduction in hepatitis B virus infections and chronic disease globally. Screening to establish extent of vaccine induced immune response and provision of booster dose are limited in most low-and-middle income countries (LMICs). Our study investigated the extent of protective immune response and breakthrough hepatitis B virus infections among adult vaccinated healthcare workers in selected health facilities in northern Uganda. A cross-sectional study was conducted among 300 randomly selected adult hepatitis B vaccinated healthcare workers in Lira and G

APA, Harvard, Vancouver, ISO, and other styles

30

Santos, Carina Carvalho dos, Beo Oliveira Leite, Fernanda Washington de Mendonça Lima, et al. "Prevalence of hepatitis among young men who have sex with men and transgender women in Brazil." Revista de Saúde Pública 58, Supl.1 (2024): 1–12. https://doi.org/10.11606/s1518-8787.2024058005555.

Full text

Abstract:

OBJECTIVE: Viral hepatitis and sexually transmitted infections disproportionally affect men who have sex with men (MSM) and transgender women (TGW). However, only a few studies have evaluated the prevalence of hepatitis in these populations, especially in youths and adolescents. This study aimed to estimate the prevalence of biomarkers for hepatitis A, B, and C among young and adolescent MSM and TGW in three Brazilian municipalities. METHODS: Baseline data were collected from a combination of HIV prevention cohort ofyoung and adolescent MSM (AMSM) and TGW (ATGW) aged 15-19 years in three Brazi

APA, Harvard, Vancouver, ISO, and other styles

31

Lin, W. T., Y. M. Chen, D. Y. Chen, et al. "Increased risk of hepatitis B virus reactivation in systemic lupus erythematosus patients receiving immunosuppressants: a retrospective cohort study." Lupus 27, no. 1 (2017): 66–75. http://dx.doi.org/10.1177/0961203317711009.

Full text

Abstract:

Objective We aimed to investigate risk of hepatitis B virus reactivation in systemic lupus erythematosus patients with different hepatitis B virus infection statuses receiving immunosuppressive therapy. Methods We retrospectively analyzed systemic lupus erythematosus patients with positive hepatitis B surface antigen or anti-hepatitis B core IgG antibody who underwent immunosuppressive therapies from January 2001 to December 2012 at a medical center in Taiwan for evidence of hepatitis B virus reactivation. Results During this period, 906 out of 3125 patients who were diagnosed with systemic lu

APA, Harvard, Vancouver, ISO, and other styles

32

Leroux-Roels, Geert, Edwige Haelterman, Cathy Maes, et al. "Randomized Trial of the Immunogenicity and Safety of the Hepatitis B Vaccine Given in an Accelerated Schedule Coadministered with the Human Papillomavirus Type 16/18 AS04-Adjuvanted Cervical Cancer Vaccine." Clinical and Vaccine Immunology 18, no. 9 (2011): 1510–18. http://dx.doi.org/10.1128/cvi.00539-10.

Full text

Abstract:

ABSTRACTThe human papillomavirus type 16/18 (HPV-16/18) AS04-adjuvanted cervical cancer vaccine is licensed for females aged 10 years and above and is therefore likely to be coadministered with other licensed vaccines, such as hepatitis B. In this randomized, open-label study, we compared the immunogenicity of the hepatitis B vaccine administered alone (HepB group) or with the HPV-16/18 AS04-adjuvanted vaccine (HepB+HPV group) in healthy women aged 20 to 25 years (clinical trial NCT00637195). The hepatitis B vaccine was given at 0, 1, 2, and 12 months (an accelerated schedule which may be requ

APA, Harvard, Vancouver, ISO, and other styles

33

Khamidulina, Anna A., Irina L. Solovеva, Mikhail P. Kostinov, et al. "Evaluation of Post-Vaccination Immunity in Children and Adolescents after Viral Hepatitis B Vaccine." Pediatric pharmacology 21, no. 1 (2024): 24–31. http://dx.doi.org/10.15690/pf.v21i1.2715.

Full text

Abstract:

Vaccination against viral hepatitis B is an effective method of protection against this infection. There is multiple decrease in the hepatitis B incidence. However, there was increase in chronic hepatitis B by 42.5%, 15 cases of acute viral hepatitis B in children and 2 deaths from this infection were registered according to the state report “On the sanitary and epidemiological wellbeing of the population of the Russian Federation for 2022”. The criteria for evaluating protection against viral hepatitis B are the anti-HBs level and the duration of post-vaccination immunity.Objective. The aim o

APA, Harvard, Vancouver, ISO, and other styles

34

Moradpour and Blum. "Diagnostik der Hepatitis B und C." Praxis 94, no. 3 (2005): 66–72. http://dx.doi.org/10.1024/0369-8394.94.3.66.

Full text

Abstract:

Die Diagnose der Hepatitis B und C kann heute mit hoher Sensitivität und Spezifität durch einfache und kostengünstige serologische Tests gesichert werden. Als Suchtests werden HBsAg bzw. anti-HBc für die Hepatitis B und anti-HCV für die Hepatitis C eingesetzt. Im Hinblick auf eine antivirale Therapie und für das Monitoring unter Therapie sind der Nachweis von HBeAg bzw. HBV DNA bei der Hepatitis B und die Bestimmung des Genotyps sowie der qualitative bzw. quantitative Nachweis der HCV RNA bei der Hepatitis C heute Standard. Eine Leberbiopsie zur Objektivierung des Entzündungsgrades und des Fib

APA, Harvard, Vancouver, ISO, and other styles

35

Nayak, Akshatha P., Insha Firoz, Ravindra Prabhu, Jayanth Nayak, Veena NK, and Megha Nagaraj Nayak. "Development of Immunity to Hepatitis B Virus Following Hepatitis B Vaccination in Hemodialysis Patient." Annals of International Medical and Dental Research 9, no. 2 (2023): 20–23. http://dx.doi.org/10.53339/aimdr.2023.9.2.4.

Full text

Abstract:

Background: Hepatitis B infection is common in Dialysis population. Hemodialysis patients have high risk of hepatitis B virus transmission not only due to frequent blood or blood product transmission, decreased response to Hepatitis B vaccine and length on hemodialysis but also due to their immunosuppressed state. Hepatitis B vaccination has the potential to reduce the risk of HBsAg infection in dialysis units. Effective vaccination, blood donor screening, the use of erythropoietin and the isolation of HBV carriers have successfully regulated HBV infection in hemodialysis units (1). This study

APA, Harvard, Vancouver, ISO, and other styles

36

Beath, S. V., E. H. Boxall, R. M. Watson, M. J. Tarlow, and D. A. Kelly. "Fulminant hepatitis B in infants born to anti-HBe hepatitis B carrier mothers." BMJ 304, no. 6835 (1992): 1169–70. http://dx.doi.org/10.1136/bmj.304.6835.1169.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Setiawan, Doni. "KONSENTRASI ANTI-HBs PADA KARYAWAN RUMAH SAKIT YANG TELAH MELAKUKAN VAKSINASI HEPATITIS B." Masker Medika 11, no. 1 (2023): 55–61. http://dx.doi.org/10.52523/maskermedika.v11i1.518.

Full text

Abstract:

Introduction: Anti-HBs (Anti HepatitisLBLsurface) is an antibodyLto hepatitisLB that arises from the administration of the hepatitis B vaccine. Hospital employees areLat high riskLof contracting the hepatitis B virus, because they often have direct contact with patients, body fluids and medical equipment infected. ThisLstudy aims to determine the presence of hepatitis B antibodies in Ciamis Hospital employees after three years of vaccination. Method: ThisLstudy usedLa qualitativeLdescriptive methodLand was conducted in 2019. The population was 30 Ciamis Hospital employees who had received Hepa

APA, Harvard, Vancouver, ISO, and other styles

38

Eremeeva, Zh G., I. K. Minullin, O. V. Platonova, E. V. Bogdanova, and V. Kh Fazylov. "Diagnosis and specific prevention of hepatitis b in a specialized setting." Kazan medical journal 96, no. 6 (2015): 923–29. http://dx.doi.org/10.17750/kmj2015-923.

Full text

Abstract:

Aim. To evaluate the diagnostic approaches to viral hepatitis B and immune response on hepatitis B vaccination among clinical dispensary of dermatology and sexually transmitted diseases medical staff. Methods. The study included 92 serum samples of healthcare facility staff who underwent hepatitis B vaccination more than 7 years before. To assess the post-vaccination immunity, levels of antibodies to surface antigen of hepatitis B (anti-HBS) were determined by ELISA. Published data on the duration of post-vaccination immunity and annual reporting forms of clinical dispensary of dermatolo

APA, Harvard, Vancouver, ISO, and other styles

39

DROBENIUC, J., Y. J. F. HUTIN, R. HARPAZ, et al. "Prevalence of hepatitis B, D and C virus infections among children and pregnant women in Moldova: additional evidence supporting the need for routine hepatitis B vaccination of infants." Epidemiology and Infection 123, no. 3 (1999): 463–67. http://dx.doi.org/10.1017/s0950268899003003.

Full text

Abstract:

Rates of acute hepatitis B are high in Moldova, but the prevalence of chronic infection is unknown. In 1994, we surveyed children and pregnant women, collected demographic information, and drew blood for laboratory testing. Among the 439 children (mean age, 5 years), the prevalence of antibody to hepatitis B core antigen (anti-HBc) and hepatitis B surface antigen (HBsAg) were 17·1 and 6·8%, respectively. Among the 1098 pregnant women (mean age, 26 years), 52·4% were anti-HBc-positive and 9·7% were HBsAg-positive. Of the HBsAg-positive pregnant women, 35·6% were hepatitis B e antigen (HBeAg) po

APA, Harvard, Vancouver, ISO, and other styles

40

Playford, E. Geoffrey, Patrick G. Hogan, Amolak S. Bansal, et al. "Intradermal Recombinant Hepatitis B Vaccine for Healthcare Workers Who Fail to Respond to Intramuscular Vaccine." Infection Control & Hospital Epidemiology 23, no. 2 (2002): 87–90. http://dx.doi.org/10.1086/502012.

Full text

Abstract:

Objective:To study the humoral immune responses, safety, and tolerability of intradermal recombinant hepatitis B vaccination in healthcare workers (HCWs) nonresponsive to previous repeated intramuscular vaccination.Design:An open, prospective, before–after trial.Setting:A tertiary referral hospital and surrounding district health service in Queensland, Australia.Participants:Hospital and community HCWs nonresponsive to previous intramuscular hepatitis B vaccination.Methods:Intradermal recombinant hepatitis B vaccine was administered every second week for a maximum of 4 doses. Hepatitis B surfa

APA, Harvard, Vancouver, ISO, and other styles

41

Fujisawa, Tomoo, Haruki Komatsu, Ayano Inui, et al. "Long‐term Outcome of Chronic Hepatitis B in Adolescents or Young Adults in Follow‐up From Childhood." Journal of Pediatric Gastroenterology and Nutrition 30, no. 2 (2000): 201–6. http://dx.doi.org/10.1002/j.1536-4801.2000.tb02703.x.

Full text

Abstract:

ABSTRACTBackground:It has not yet been defined whether children with chronic hepatitis B are likely to develop severe liver disease in the future. The purpose of this study was to evaluate the evolution of chronic hepatitis B acquired in childhood.Method:Fifty‐two children in the age range of 0 to 15 years who were positive for hepatitis B surface antigen and hepatitis B e antigen in serum for at least 6 months were enrolled in this study. In the majority of the 52 children, hepatitis B virus infection was acquired by perinatal transmission. All 52 showed abnormal liver function test findings

APA, Harvard, Vancouver, ISO, and other styles

42

RICHTER, C., G. TER BEEST, I. SANCAK, et al. "Hepatitis B prevalence in the Turkish population of Arnhem: implications for national screening policy?" Epidemiology and Infection 140, no. 4 (2011): 724–30. http://dx.doi.org/10.1017/s0950268811001270.

Full text

Abstract:

SUMMARYDespite the increased prevalence of hepatitis B and C in most migrant groups in The Netherlands, a national screening policy for these infections is not available. In order to estimate the prevalence of hepatitis B and C in the largest group of first-generation migrants (FGM) in The Netherlands, we conducted a screening project in the Turkish community of Arnhem. In a separate project we identified patients from the target population with chronic hepatitis B and C from hospital records (1990–2008). Educational meetings concerning hepatitis were organized, with all participants being off

APA, Harvard, Vancouver, ISO, and other styles

43

Ahmad, Gulzar, Muhammad Adnan Khan, Sagheer Abbas, Atifa Athar, Bilal Shoaib Khan, and Muhammad Shoukat Aslam. "Automated Diagnosis of Hepatitis B Using Multilayer Mamdani Fuzzy Inference System." Journal of Healthcare Engineering 2019 (February 5, 2019): 1–11. http://dx.doi.org/10.1155/2019/6361318.

Full text

Abstract:

In this research, a new multilayered mamdani fuzzy inference system (Ml-MFIS) is proposed to diagnose hepatitis B. The proposed automated diagnosis of hepatitis B using multilayer mamdani fuzzy inference system (ADHB-ML-MFIS) expert system can classify the different stages of hepatitis B such as no hepatitis, acute HBV, or chronic HBV. The expert system has two input variables at layer I and seven input variables at layer II. At layer I, input variables are ALT and AST that detect the output condition of the liver to be normal or to have hepatitis or infection and/or other problems. The furthe

APA, Harvard, Vancouver, ISO, and other styles

44

Tsutsumi, Y., S. Kakumu, T. Wakita, K. Yoshioka, and T. Ishikawa. "In vitro production of antibody to hepatitis B core and E antigens by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection." Journal of Immunology 144, no. 6 (1990): 2389–93. http://dx.doi.org/10.4049/jimmunol.144.6.2389.

Full text

Abstract:

Abstract To evaluate the relative immunogenicity of and the mechanism for production of antibody to hepatitis B core (HBc) and hepatitis B e (HBe) Ag, we investigated the in vitro anti-HBc and anti-HBe production by PBMC from 25 patients with chronic active hepatitis (CAH) (15 with HBeAg and 10 with anti-HBe) and 12 ASC (5 with HBeAg and 7 with anti-HBe) in the presence of PWM, rHBcAg, or purified HBeAg. PWM-stimulated culture produced higher titer anti-HBc (mean % inhibition +/- SD = 73 +/- 23%, p less than 0.001) than anti-HBe (34 +/- 17%). HBcAg stimulation elicited greater anti-HBc respons

APA, Harvard, Vancouver, ISO, and other styles

45

BAGHBANIAN, Mahmud, Mehdi HALVANI, Hassan Salman ROGHANI, Mohammad Hassan LOTFI, Mohammad Frahat YAZDI, and Hassan-Ali VAHEDIAN-ARDAKANI. "PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT." Arquivos de Gastroenterologia 53, no. 3 (2016): 175–79. http://dx.doi.org/10.1590/s0004-28032016000300010.

Full text

Abstract:

ABSTRACT Background Occult hepatitis B infection is characterized by negative hepatitis B surface antigen (HBsAg) and also detectable hepatitis B virus (HBV) -DNA, with or without hepatitis B core antibody (anti-HBc). HBV reactivation in individuals under immunosuppressive therapy is critical, occurring in occult HBV. Objective In this study, we aimed to determine the prevalence of occult HBV infection among hepatitis B surface antigen negative in cancer patients before receiving chemotherapy. Methods Sera from 204 cancer patients who were negative for HBsAg, were tested for anti-HBc antibodie

APA, Harvard, Vancouver, ISO, and other styles

46

Morgan-Capner, P., P. Hudson, and A. Armstrong. "Hepatitis B markers in Lancashire police officers." Epidemiology and Infection 100, no. 1 (1988): 145–51. http://dx.doi.org/10.1017/s0950268800065638.

Full text

Abstract:

SUMMARYA total of 284 Lancashire police officers each with a minimum of 5 years experience was tested for evidence of hepatitis B infection. None was hepatitis B surface antigen positive (HBsAg). Three were positive for both antibody to hepatitis B core antigen (anti-HBc) and HBsAg (anti-HBs). Five were positive for anti-HBc alone. Thus the overall prevalence was 2·8% which is within the range reported for blood donors in the UK. There was no association with working in the drug squad or custody office but there was a higher prevalence in those who had worked in the scene-of-crime's squad. How

APA, Harvard, Vancouver, ISO, and other styles

47

Rampengan, Novie Homenta, Sri Rezeki Hadinegoro, and Mulya Rahma Karyanti. "Hepatitis B seroprotection in children aged 10-15 years after completion of basic hepatitis B immunizations." Paediatrica Indonesiana 57, no. 2 (2017): 76. http://dx.doi.org/10.14238/pi57.2.2017.76-83.

Full text

Abstract:

Background The prevalence of hepatitis B viral (HBV) infection in Indonesia is high. The most effective way to control HBV infection is by hepatitis B (HB) immunization. Many studies reported that hepatitis B surface antibody (anti-HBs) seroprotection declines in children > 10 years of age. In addition many factors can influence anti-HBs titer.Objective To measure anti-HBs titer and evaluate possible factors associated with anti-HBs titer.Methods This cross sectional study was conducted in children 10-15 years of age from ten schools at Tuminting District, Manado, North Sulawesi, from Octob

APA, Harvard, Vancouver, ISO, and other styles

48

Sulistina, Dewi Ratna. "Effectiveness of Hepatitis B Vaccination on Various Populations: A Systematic Review." Asian Journal of Health Research 1, no. 2 (2022): 64–74. http://dx.doi.org/10.55561/ajhr.v1i2.43.

Full text

Abstract:

Introduction: Hepatitis B vaccination is important to protect individuals from Hepatitis B virus (HBV) infection. The aim of this study was to conduct a systematic review of the necessity of Hepatitis B vaccination among humans, especially among infants, children, teenagers, adults, risk groups, and health care workers. Methods: Three databases were used in this study, Scopus, Web of Science, and PubMed. We reported the study using PRISMA-P guidelines. The keywords were used in this study (TITLE-ABS-KEY (vaccine) AND TITLE-ABS-KEY (hepatitis AND b) AND TITLE-ABS-KEY (boost)), and we obtained 2

APA, Harvard, Vancouver, ISO, and other styles

49

Shen, Sijia, Shen Ge, Zheng Zhang, et al. "Persistence of Immunity in Adults after 1, 5 and 10 Years with Recombinant Hepatitis B Vaccine in Beijing in 2010–2020." Vaccines 10, no. 2 (2022): 181. http://dx.doi.org/10.3390/vaccines10020181.

Full text

Abstract:

The persistence of immunity after hepatitis B vaccination is still under investigation in adults. In Chaoyang District, Beijing, people who were aged ≥ 18 years and completely immunized with HBV vaccine according to the standard procedure (0–1–6 months) were enrolled. Three groups were set for 1 (Y1), 5 (Y5) and 10 (Y10) years after the hepatitis B vaccination. The following data was collected and analyzed: antibody against hepatitis B virus surface antigen(anti-HBs) positive rates and geometric mean concentration (GMC) between the different compared groups through questionnaires and laborator

APA, Harvard, Vancouver, ISO, and other styles

50

Sahin, Meyha, and Meltem Yazla. "Change in Rates of HBsAg and Anti-HBs in Şırnak 20 Years After Introduction of Hepatitis B Vaccine into Routine Infant Immunization Program." Infectious Diseases and Clinical Microbiology 5, no. 2 (2023): 153–57. http://dx.doi.org/10.36519/idcm.2023.231.

Full text

Abstract:

Objectives: This study aimed to monitor the change in the rate of hepatitis B infections in Şırnak, a province in south-eastern Turkey, and to determine the rate of immunization for hepatitis B in this region after the national immunization program covered hepatitis B. Materials and Methods: This retrospective study included patients born in 1998 or after and applied to different outpatient clinics in the province between April 2017 and June 2018. Patients in this study were screened for HBsAg and anti-HBs for various reasons. We analyzed confirmed HBsAg and anti-HBs positive results according

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!